red blood cells have altered metabolism
https://search.proquest.com/openview/25 ... 750&diss=y
Glucose  transporter  1  (GLUT1)  is  the  main  glucose  transporter  on  RBCs,  and all metabolism  within  theRBC  involves  glucose.RBC  GLUT1  content  was  used  as  a measure  of  RBC  metabolism,  andelevated RBC  GLUT1  content  is  proposed  to  be associated
with increased cell metabolism.RBCs obtained from MS patients contained 23.3± 4.8% more GLUT1 than control RBCs, while T1D RBCs 
contained 23.6± 4.2% less GLUT1than control RBCs.Further studies evaluated the effects of various therapies on RBCs with respect to MS and T1D.
Steroids  are  commonly  prescribed  to  MS  patients  to  manage  exacerbations  of  the disease;however,hyperglycemic conditions often result. Evidence presented here using measurements of RBC adenosine triphosphate (ATP) release, suggests that the steroids estriol and prednisolone decrease RBC metabolism. ATP is a product of glycolysis, which utilizes the glucose transported into the cell to produce 
energy.
While MS RBCs released104±  18nM  more  ATP  than  control  RBCs, treatment  with  estriol  or  prednisolone
PREVIEW
significantly decreased the RBC ATP release , thought to correlate to RBC metabolism. RBC  ATP  release  stimulates  endothelial  nitric  oxide  (NO)  production in  vivo,  which  is detrimental at the high  levels seenin  MS  due  to  its  toxicity  to  the  blood  brain  barrier. 
Results presented here also suggest that RBCs treated with physiological levels of estriol or prednisolone significantly decrease the downstream endothelial NO production up to 30%, thought to correlate to decreased blood brain barrier damage in MS patients
			
			
									
						
										
						red blood cells have altered metabolism
A forum to discuss Chronic Cerebrospinal Venous Insufficiency and its relationship to Multiple Sclerosis.
			Return to “Chronic Cerebrospinal Venous Insufficiency (CCSVI)”
			
				Jump to
				
			
		
			
			
	
	- Multiple Sclerosis
- ↳ General Discussion
- ↳ Introductions
- ↳ Drug Pipeline
- ↳ Regimens
- ↳ Undiagnosed
- ↳ MS Etiology and Pathogenesis
- Treatments
- ↳ Chronic Cerebrospinal Venous Insufficiency (CCSVI)
- ↳ Low Dose Naltrexone
- ↳ Tysabri (Antegren, Natalizumab)
- ↳ Copaxone
- ↳ Glatopa
- ↳ Avonex
- ↳ Rebif
- ↳ Betaseron
- ↳ Plegridy
- ↳ Novantrone
- ↳ Aimspro
- ↳ Diet
- ↳ Stem Cells
- ↳ Antibiotics
- ↳ Campath (Lemtrada, Alemtuzumab)
- ↳ Gene Therapy
- ↳ Natural Approach
- ↳ Biotin (Qizenday, Cerenday, MD1003)
- ↳ Coimbra High-Dose Vitamin D Protocol
- ↳ Statins
- ↳ Tcelna (Tovaxin)
- ↳ Revimmune (Cyclophosphamide, Cytoxan)
- ↳ Medical Devices
- ↳ Rituxan (Rituximab)
- ↳ Ocrevus (Ocrelizumab)
- ↳ Kesimpta (Ofatumumab)
- ↳ Briumvi (Ublituximab-xiiy)
- ↳ General Medications
- ↳ Tecfidera (BG-12, Dimethyl fumarate)
- ↳ Vumerity (Diroximel fumarate)
- ↳ Bafiertam (Monomethyl fumarate)
- ↳ Gilenya
- ↳ Aubagio (Teriflunomide)
- ↳ Mayzent (Siponimod)
- ↳ Zeposia (Ozanimod)
- ↳ Ponvory (Ponesimod)
- ↳ Mavenclad (Cladribine)
- ↳ Ampyra (Dalfampridine)
- ↳ Medical Marijuana
- ↳ Sativex
- ↳ Chiropractic Treatment
- Life
- ↳ Daily Life
- ↳ Veterans and MS
- ↳ Trigeminal Neuralgia in MS
- ↳ Reading Nook
- ↳ Humor
- ↳ Shopping
- ↳ Friends and Family
- ↳ Mental & Spiritual Health
- ↳ Exercise and Physical Therapy
- ↳ Under 25 with MS
- ↳ MS in the Golden Years
- ↳ Parenting Kids With MS
- ↳ Parents with MS
- ThisIsMS.com
- ↳ Site Support
- ↳ Suggestions
